Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy
About this study
CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
- Condition
- Type 2 Diabetes
- Tested
- data collection
- Sponsor
- Federico II University
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 7
- Minimum age: 18 years
- Study condition: Type 2 Diabetes
- Age ≥ 18 years;
- Diagnosis of type 2 diabetes mellitus (T2DM);
- Stable clinical conditions
- Outpatient settings
- Ability to understand the study procedures and provide written informed consent.
Exclusion 3
- Patients with type 1 diabetes mellitus;
- Active participation in interventional studies;
- Any condition that may put the patient at risk by participating in the study.
Where
1 site, 1 recruiting
Federico II University of Naples, Department of Advanced Biomedical Sciences
Naples, Napoli, Italy
Contact
-
Pasquale Perrone Filardi
+39081/746224 fpperron@unina.it
Potential match only. Final eligibility is determined by the study team.